Article Text

PDF
Paper
Assent as an ethical imperative in the treatment of ADHD
  1. Anson J Koshy1,
  2. Dominic A Sisti2
  1. 1Department of Pediatrics, Children's Learning Institute, The University of Texas Health Science Center at Houston, Houston, Texas, USA
  2. 2Department of Medical Ethics & Health Policy, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
  1. Correspondence to Dr Anson J Koshy, Department of Pediatrics, Children's Learning Institute, The University of Texas Health Science Center at Houston, 6655 Travis Ste. 880, Houston, TX 77030, USA; anson.j.koshy{at}uth.tmc.edu

Abstract

The American Academy of Paediatrics endorses obtaining assent when prescribing medications for attention-deficit/hyperactivity disorder (ADHD) in older children whenever possible. Studies indicate the concept of assent may not be well understood by clinicians, possibly effecting effective and widespread implementation. We argue that though the concept of assent continues to evolve, it is critical in the context of patient-centred care, shared decision-making and in supporting minors’ transition to adulthood. Based on the principle of respect for young persons, we argue that obtaining assent is an ethical imperative when prescribing medication for ADHD. We highlight the instrumental benefits of obtaining assent in the paediatric clinical encounter when prescribing medications for treatment of ADHD.

  • Children
  • Paediatrics
  • Informed Consent
  • Decision-making

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.